Skip to main content
. 2018 Sep 14;6(3):64. doi: 10.3390/vaccines6030064
BALF bronchio-alveolar lavage fluid
cHA chimeric hemagglutinin
CPE cytophathic effect
DPC days post challenge
Emul Emulsigen adjuvant
H&E staining hematoxylin and eosin staining
HA hemagglutinin
HI hemagglutination inhibition
ICS intracellular cytokine staining
IFN interferon
Ig immunoglobulin
IHC immunohistochemistry
IIV inactivated whole virus influenza vaccine
LAIV live attenuated influenza virus vaccine
MDCK Madin Darby canine kidney
MEM minimal essential medium
NP nucleoprotein
PBMCs peripheral blood mononuclear cells
PFU Plaque forming units
TCID50 tissue culture infectious dose 50
TIV trivalent inactivated virus vaccine
TPCK tosyl phenylalanyl chloromethyl ketone
VAERD vaccine-associated enhanced respiratory disease